[
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
[og_img]
https://www.investing.com/news/press-releases/update-springworks-therapeutics-announces-fda-approval-of-gomekli-mirdametinib-for-the-treatment-of-adult-and-pediatric-patients-with-nf1pn-93CH-3863313
Investing.com
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Related articles
